Ausgabe 6/2019
Inhalt (17 Artikel)
The Role of Nav1.8 in Cardiac Electrophysiology—a Matter of the Heart or the Nerve?
Katja E. Odening
Absence of Functional Nav1.8 Channels in Non-diseased Atrial and Ventricular Cardiomyocytes
Simona Casini, Gerard A. Marchal, Makiri Kawasaki, Fransisca A. Nariswari, Vincent Portero, Nicoline W.E. van den Berg, Kaomei Guan, Antoine H.G. Driessen, Marieke W. Veldkamp, Isabella Mengarelli, Joris R. de Groot, Arie O. Verkerk, Carol Ann Remme
Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues—Liraglutide and Semaglutide
Maryna V. Basalay, Sean M. Davidson, Derek M. Yellon
The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart
Mitchel Tate, Gavin C. Higgins, Miles J. De Blasio, Runa Lindblom, Darnel Prakoso, Minh Deo, Helen Kiriazis, Min Park, Carlos D. Baeza-Garza, Stuart T. Caldwell, Richard C. Hartley, Thomas Krieg, Michael P. Murphy, Melinda T. Coughlan, Rebecca H. Ritchie
LncRNA MALAT1 Promotes Oxygen-Glucose Deprivation and Reoxygenation Induced Cardiomyocytes Injury Through Sponging miR-20b to Enhance beclin1-Mediated Autophagy
Shuang Wang, Tao Yao, Fan Deng, Wenqian Yu, Yiting Song, Jingyi Chen, Zhihua Ruan
A Novel Epigenetic Drug-Eluting Balloon Angioplasty Device: Evaluation in a Large Animal Model of Neointimal Hyperplasia
HongBin Liu, Melissa Byrne, Patrick Perlmutter, Ashley Walker, Gopal R. Sama, Jegadesan Subbiah, Berkay Ozcelik, Robert E. Widdop, Tracey A. Gaspari, Keith Byron, Yung-Chih Chen, David M. Kaye, Anthony E. Dear
Association of Regulatory Genetic Variants for Protein Kinase Cα with Mortality and Drug Efficacy in Patients with Heart Failure
Jasmine A. Luzum, Christopher Ting, Edward L. Peterson, Hongsheng Gui, Tyler Shugg, L. Keoki Williams, Liang Li, Wolfgang Sadee, Danxin Wang, David E. Lanfear
Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis
Yi-Hsin Chan, Hsin-Fu Lee, Tze-Fan Chao, Chia-Tung Wu, Shang-Hung Chang, Yung-Hsin Yeh, Lai-Chu See, Chi-Tai Kuo, Pao-Hsien Chu, Chun-Li Wang, Gregory Y. H. Lip
Omitting aspirin in PCI patients: Myth or reality?
Dimitrios Alexopoulos, Aikaterini Mpahara, George Kassimis
Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management
Michele Correale, Lucia Tricarico, Davide Grazioli, Ennio Sascia Formica, Rossella Petrucci, Paola Persichella, Matteo Di Biase, Natale Daniele Brunetti
Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Current Understanding and Future Perspectives
M. F. Wu, K. Z. Xu, Y. G. Guo, J. Yu, Y. Wu, L. M. Lin
Fibrinolysis: a Misunderstood Natural Defense Whose Therapeutic Potential Is Unknown
Victor Gurewich
The Effect of Ranolazine on Glycemic Control: a Narrative Review to Define the Target Population
Dusty Lisi, Ebony Andrews, Chelsea Parry, Catrina Hill, David Ombengi, Hua Ling
Prediabetes with Hypertension and Dyslipidemia: Are They Triad of Future Cardiovascular Risk?
Venu Gopal Jonnalagadda
Activation of T Lymphocytes as a Novel Mechanism in Beta1-Adrenergic Receptor Autoantibody-Induced Cardiac Remodeling—Additional Information About TLR9 Involvement
Annekathrin Haberland, Johannes Müller, Katrin Wenzel